The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Systemic therapy usage and outcomes for patients diagnosed with malignant pleural mesothelioma (MPM) between 2005 and 2010 in Ontario, Canada.
A. Hasani
No relevant relationships to disclose
B. Sun
No relevant relationships to disclose
G. Liu
No relevant relationships to disclose
W. Xu
No relevant relationships to disclose
R. Feld
Research Funding - Lilly
N. B. Leighl
No relevant relationships to disclose